GSK and ViiV Healthcare confirmed today that the US District Court for the District of Delaware upheld the validity of a patent covering the double combination of? lamivudine and abacavir (Epzicom?) and the triple combination of lamivudine, ...
Tags: GSK, ViiV, Lupin Generic, Trizivir Patent